← All trials
NCT07167862
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2025
- Primary completion
- Nov 8, 2025
- Completion date
- Mar 15, 2027
- First posted
- Sep 11, 2025
- Last posted
- Sep 26, 2025
- Enrollment
- 96
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, IrvineLead sponsor
- University of California, IrvineOfficial
- University of California, IrvineSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.